CTLA4 and melanoma: For this, we sought to evaluate the potential cooperative effects of RT and PIC in priming a response to the ICB anti-CTLA-4 in a well-established (4 weeks post implantation), immunologically “cold” B78 melanoma model that does not respond to ICBs alone (Fig. 5a)7.